Maureen S Durkin1,2,3, Ruth E Benedict2,4, Deborah Christensen5, Lindsay A Dubois1,2, Robert T Fitzgerald6, Russell S Kirby7, Matthew J Maenner5, Kim Van Naarden Braun5, Martha S Wingate8, Marshalyn Yeargin-Allsopp5. 1. Department of Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI. 2. Waisman Center, University of Wisconsin-Madison, Madison, WI. 3. Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, WI. 4. Department of Kinesiology, University of Wisconsin-Madison, Madison, WI. 5. Centers for Disease Control and Prevention, Atlanta, GA. 6. Department of Psychiatry, Washington University School of Medicine, St Louis, MO. 7. Department of Community and Family Health, College of Public Health, University of South Florida, Tampa, FL. 8. Department of Health Care Organization and Policy, School of Public Health, University of Alabama at Birmingham, Birmingham, AL.
Abstract
BACKGROUND: The public health objective for cerebral palsy (CP) in the United States is to reduce the percentage of children with CP who were born low birthweight (LBW, <2500 g) by 10% between 2006 and 2020. This study reports the prevalence of CP in a constant surveillance area for the years 2006, 2008, and 2010 and describes initial progress towards the CP public health objective. METHODS: Data on children with CP at age 8 years were ascertained by the Autism and Developmental Disabilities Monitoring (ADDM) Network, a population-based surveillance system that monitored CP in four areas of the United States. RESULTS: CP prevalence in 2010 was 2.9 per 1000 [95% confidence interval (CI) 2.6, 3.2], down from 3.5 (95% CI 3.2, 3.9) in the same surveillance area in 2006. Among CP cases with no documented postneonatal aetiology, 49.1% (95% CI 42.9, 55.2) were born LBW in 2010 compared with 54.3% (95% CI 48.4, 60.1) in 2006. In 2010, 28.1% (95% CI 22.9, 30.4) were born very low birthweight (VLBW, <1500 g) compared with 35.4% (95% CI 30.0, 41.2) in 2006. The relative risks for associations between CP and both LBW and VLBW also declined, though not significantly, during the study period. CONCLUSIONS: Declines in the associations between CP and LBW categories may have contributed to declines during the study period in both the prevalence of CP and the percentage of children with CP who were born LBW or VLBW. Ongoing monitoring of these trends is warranted.
BACKGROUND: The public health objective for cerebral palsy (CP) in the United States is to reduce the percentage of children with CP who were born low birthweight (LBW, <2500 g) by 10% between 2006 and 2020. This study reports the prevalence of CP in a constant surveillance area for the years 2006, 2008, and 2010 and describes initial progress towards the CP public health objective. METHODS: Data on children with CP at age 8 years were ascertained by the Autism and Developmental Disabilities Monitoring (ADDM) Network, a population-based surveillance system that monitored CP in four areas of the United States. RESULTS: CP prevalence in 2010 was 2.9 per 1000 [95% confidence interval (CI) 2.6, 3.2], down from 3.5 (95% CI 3.2, 3.9) in the same surveillance area in 2006. Among CP cases with no documented postneonatal aetiology, 49.1% (95% CI 42.9, 55.2) were born LBW in 2010 compared with 54.3% (95% CI 48.4, 60.1) in 2006. In 2010, 28.1% (95% CI 22.9, 30.4) were born very low birthweight (VLBW, <1500 g) compared with 35.4% (95% CI 30.0, 41.2) in 2006. The relative risks for associations between CP and both LBW and VLBW also declined, though not significantly, during the study period. CONCLUSIONS: Declines in the associations between CP and LBW categories may have contributed to declines during the study period in both the prevalence of CP and the percentage of children with CP who were born LBW or VLBW. Ongoing monitoring of these trends is warranted.
Authors: Russell S Kirby; Martha S Wingate; Kim Van Naarden Braun; Nancy S Doernberg; Carrie L Arneson; Ruth E Benedict; Beverly Mulvihill; Maureen S Durkin; Robert T Fitzgerald; Matthew J Maenner; Jean A Patz; Marshalyn Yeargin-Allsopp Journal: Res Dev Disabil Date: 2011-01-26
Authors: Matthew J Maenner; Ruth E Benedict; Carrie L Arneson; Marshalyn Yeargin-Allsopp; Martha S Wingate; Russell S Kirby; Kim Van Naarden Braun; Maureen S Durkin Journal: Epidemiology Date: 2012-01 Impact factor: 4.822
Authors: Ilan Arad; Maureen S Durkin; Veronica J Hinton; Louise Kuhn; Claudia Chiriboga; Karl Kuban; David Bellinger Journal: Am J Obstet Gynecol Date: 2002-04 Impact factor: 8.661
Authors: Marshalyn Yeargin-Allsopp; Kim Van Naarden Braun; Nancy S Doernberg; Ruth E Benedict; Russell S Kirby; Maureen S Durkin Journal: Pediatrics Date: 2008-03 Impact factor: 7.124
Authors: Joyce A Martin; Brady E Hamilton; Stephanie J Ventura; Michelle J K Osterman; Elizabeth C Wilson; T J Mathews Journal: Natl Vital Stat Rep Date: 2012-08-28
Authors: Dana Olzenak McGuire; Lin H Tian; Marshalyn Yeargin-Allsopp; Nicole F Dowling; Deborah L Christensen Journal: Disabil Health J Date: 2019-01-23 Impact factor: 2.554
Authors: Qing Li; Stephen L Kinsman; Dorothea D Jenkins; Melbourne F Hovell; Rita M Ryan Journal: Dev Med Child Neurol Date: 2018-11-12 Impact factor: 5.449
Authors: Catherine Arnaud; Virginie Ehlinger; Malika Delobel-Ayoub; Dana Klapouszczak; Oliver Perra; Owen Hensey; David Neubauer; Katalin Hollódy; Daniel Virella; Gija Rackauskaite; Andra Greitane; Kate Himmelmann; Els Ortibus; Ivana Dakovic; Guro L Andersen; Antigone Papavasiliou; Elodie Sellier; Mary Jane Platt; Inge Krägeloh-Mann Journal: Front Neurol Date: 2021-05-20 Impact factor: 4.003